Institute for Health Sciences, Section of Midwifery Science, University Hospital Tübingen, Tübingen, Germany.
Hospital for General Obstetrics and Gynecology, University Hospital Heidelberg, Heidelberg, Germany.
J Med Internet Res. 2022 Feb 8;24(2):e16128. doi: 10.2196/16128.
One in eight women is diagnosed with breast cancer in the course of their life. As systematic palliative treatment has only a limited effect on survival rates, the concept of health-related quality of life (HRQoL) was developed for measurement of patient-centered outcomes. Various studies have already demonstrated the reliability of paper-based patient-reported outcome (pPRO) and electronic patient-reported outcome (ePRO) surveys and that the 2 means of assessment are equally valid.
The aim of this study was to analyze the acceptance and evaluation of a tablet-based ePRO app for breast cancer patients and to examine its suitability, effort, and difficulty in the context of HRQoL and sociodemographic factors.
Overall, 106 women with adjuvant or advanced breast cancer were included in a 2-center study at 2 major university hospitals in Germany. Patients were asked to answer HRQoL and PRO questionnaires both on a tablet on-site using a specific eHealth assessment website and on paper. The suitability, effort, and difficulty of the app and self-reported technical skills were also assessed. Only the results of the electronically acquired data are presented here. The results of the reliability of the pPRO data have already been published elsewhere.
Patients regarded the ePRO assessment as more suitable (80/106, 75.5%), less stressful (73/106, 68.9%), and less difficult (69/106, 65.1%) than pPRO. The majority of patients stated that ePRO assessment improves health care in hospitals (87/106, 82.1%). However, evaluation of ePROs depended on the level of education (P=.003) in the dimensions of effort and difficulty (regression analysis). The app was rated highly in all categories. HRQoL data and therapy setting did not show significant correlations with the app's evaluation parameters.
The results indicate that ePRO surveys are feasible for measuring HRQoL in breast cancer patients and that those patients prefer ePRO assessment to pPRO assessment. It can also be seen that patients consider ePRO assessment to improve hospital health care. However, studies with larger numbers of patients are needed to develop apps that address the needs of patients with lower levels of education and technical skills.
每 8 名女性中就有 1 人在其一生中被诊断出患有乳腺癌。由于系统姑息治疗对生存率的影响有限,因此开发了健康相关生活质量(HRQoL)的概念来衡量以患者为中心的结果。多项研究已经证明了纸质患者报告结局(pPRO)和电子患者报告结局(ePRO)调查的可靠性,并且这两种评估方法同样有效。
本研究旨在分析一种基于平板电脑的电子患者报告结局(ePRO)应用程序在乳腺癌患者中的接受度和评估,并根据 HRQoL 和社会人口因素检查其适用性、难度和工作量。
在德国两所主要大学医院的 2 个中心进行了一项 2 中心研究,共纳入 106 名接受辅助或晚期乳腺癌治疗的女性患者。患者被要求在现场使用特定的电子健康评估网站在平板电脑上回答 HRQoL 和 PRO 问卷,并在纸上回答。还评估了应用程序的适用性、难度和工作量以及自我报告的技术技能。此处仅呈现电子方式获取的数据结果。pPRO 数据的可靠性结果已在其他地方发表。
患者认为 ePRO 评估比 pPRO 更合适(80/106,75.5%)、压力更小(73/106,68.9%)和难度更小(69/106,65.1%)。大多数患者表示,ePRO 评估可以改善医院的医疗保健(87/106,82.1%)。然而,评估取决于教育水平(P=.003),这在努力和难度维度上有所体现(回归分析)。该应用程序在所有类别中均获得了很高的评价。HRQoL 数据和治疗方案与应用程序的评估参数之间没有显著相关性。
结果表明,ePRO 调查可用于测量乳腺癌患者的 HRQoL,并且这些患者更喜欢 ePRO 评估而不是 pPRO 评估。还可以看出,患者认为 ePRO 评估可以改善医院的医疗保健。然而,需要进行更多患者数量的研究,以开发满足教育水平和技术技能较低的患者需求的应用程序。